LillyDirect vs NovoCare: GLP-1 Prices Compared

LillyDirect and NovoCare are manufacturer-backed ways to get certain GLP-1 prescriptions, but neither is automatically the cheapest option.

LillyDirect is Eli Lilly's platform. NovoCare is Novo Nordisk's. Both can offer lower self-pay prices than list price, but the drugs, dose pricing and insurance rules differ.

The simplest approach: start with the drug you were prescribed, then compare your insurance price with the manufacturer's price.

Which GLP-1s can you get through each program?

Those numbers are not interchangeable. Foundayo, Wegovy and Zepbound have weight-management indications. Ozempic and Mounjaro are diabetes medicines with different FDA-approved uses.

Your prescriber decides which medicine is appropriate. The shopping decision starts after you know what was prescribed.

Does manufacturer-direct mean you skip insurance?

No.

LillyDirect can support insurance and self-pay pathways depending on the medicine. NovoCare also offers insurance savings programs, while its NovoCare Pharmacy cash/self-pay transactions are processed outside insurance.

That creates two very different routes:

Insurance route: Your plan processes the prescription. A manufacturer savings card may reduce your remaining patient responsibility if you qualify.

Self-pay route: You pay a manufacturer-backed cash price outside insurance.

If you use the self-pay route, do not assume the payment will count toward your insurance deductible or out-of-pocket maximum.

What changed for Medicare in 2026?

This is where the comparison changes substantially.

Starting July 1, 2026, the Medicare GLP-1 Bridge gives eligible people with Part D access to:

• Foundayo tablets
• Wegovy injection or tablets
• Zepbound KwikPen

for a $50 monthly copay.

That means an eligible Medicare patient should generally check the Bridge or regular Part D coverage before choosing LillyDirect or NovoCare self-pay.

The Bridge is not normal Part D coverage. Its $50 copay does not count toward the Part D deductible or true out-of-pocket costs.

Medicare also says patients prescribed a GLP-1 for a Part D-coverable indication — such as Zepbound for moderate-to-severe obstructive sleep apnea or Wegovy for certain cardiovascular-risk reduction — should use the regular Part D pathway rather than the Bridge.

Which program is cheaper?

There is no useful "LillyDirect vs NovoCare winner" because the programs usually sell different prescriptions.

Compare this instead:

Your prescription → insurance price → manufacturer savings offer → manufacturer self-pay price → pharmacy cash price

For example, NovoCare's lowest Wegovy pill price does not make Wegovy the "cheapest" choice for someone prescribed Zepbound. Changing medication is a clinical decision.

What are the catches to check?

Manufacturer prices often come with conditions:

• A price may apply only to certain doses.
• A low introductory price may last only a few fills.
• A higher-dose discount may require refilling within a set number of days.
• Commercial savings cards may exclude government-insured patients.
• Self-pay purchases may not count toward insurance cost-sharing totals.

The headline number is only useful after you know which version of the offer applies to you.

What should I do before paying?

Ask for three numbers:

1. Your actual insurance patient responsibility
2. The manufacturer price for your exact drug and dose
3. The pharmacy cash price

Then ask whether choosing the manufacturer self-pay price takes the prescription outside your insurance benefits.

For a full price comparison, see GLP-1 cost without insurance.

Bottom line

LillyDirect and NovoCare make GLP-1 pricing more visible. That is useful.

But manufacturer-direct is another price to compare, not a reason to automatically bypass insurance.

For Medicare patients especially, check the new 2026 federal coverage pathways first.

Unblind Health provides general healthcare pricing and coverage information for educational purposes. Prices, eligibility, coverage and program terms vary and can change; confirm current information with your plan, pharmacy or the manufacturer before you pay. Never start, stop, switch or change the dose of a medication based on price alone. Talk with your prescriber or pharmacist about medication decisions. This is not medical, legal, tax or insurance advice.

Sources

• LillyDirect — checked September 11, 2026
• LillyDirect — Foundayo — checked September 11, 2026
• LillyDirect — Zepbound — checked September 11, 2026
• NovoCare Pharmacy — checked September 11, 2026
• NovoCare — Wegovy — checked September 11, 2026
• CMS — Medicare GLP-1 Bridge — checked September 11, 2026